A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study

BACKGROUND: Symptom burden, medical comorbidities, and functional well-being of patients with chronic hepatitis C virus (HCV) initiating direct acting antiviral (DAA) therapy in real-world clinical settings are not known. We characterized these patient-reported outcomes (PROs) among HCV-infected pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Evon, Donna M., Stewart, Paul W., Amador, Jipcy, Serper, Marina, Lok, Anna S., Sterling, Richard K., Sarkar, Souvik, Golin, Carol E., Reeve, Bryce B., Nelson, David R., Reau, Nancy, Lim, Joseph K., Reddy, K. Rajender, Di Bisceglie, Adrian M., Fried, Michael W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070182/
https://www.ncbi.nlm.nih.gov/pubmed/30067745
http://dx.doi.org/10.1371/journal.pone.0196908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070182/
https://www.ncbi.nlm.nih.gov/pubmed/30067745
http://dx.doi.org/10.1371/journal.pone.0196908

Ejemplares similares